Gastrointestinal adverse reactions nausea, vomiting, diarrhoea, abdominal pain and constipation are the most commonly reported reactions across these labels, and how you experience them at a starting dosage is real information for your prescriber
Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
For the obesity treatment group, there was a 6.7% NAION incidence for patients taking semaglutide compared to a 0.8% incidence rate for patients taking other medications for weight loss
Physiology, pharmacology and clinical relevance of glucagon Glucagon is a peptide hormone secreted by the alpha cells of the pancreas in response to fasting or hypoglycaemia [42]